U.S. Specialty Stores Stock News

Amylyx Pharmaceuticals has recently completed a follow-on equity offering, raising US$175 million by issuing 17,500,000 shares of common stock at US$10 per share with a US$0.60 discount per security. This sizable capital raise can enhance the company's resources for research, development, and potential commercialization activities in its pipeline. We’ll explore how this significant equity issuance shapes Amylyx Pharmaceuticals’ investment narrative and future growth opportunities in the...

If you have been following Mirion Technologies (NYSE:MIR), you may have noticed a recent flurry of headlines. Mirion has been added to several major S&P indices in quick succession, including the S&P 1000, S&P 600, S&P Composite 1500, and the S&P 600 Information Technology sector. For many investors, these moves are more than just technical reshuffling; they often translate directly into increased buying by index funds and heightened attention from the broader market. Mirion’s entry into...

Alkermes (ALKS) just made a move that is getting investors’ attention. The company announced Joshua Reed as its new Chief Financial Officer, a seasoned finance leader who has worked in both major biopharma and top financial institutions. With decades of industry experience and a track record of steering companies through complex markets, Reed’s arrival could signal a new approach to Alkermes’ financial strategy. Executive changes at this level often prompt a closer look at what is next for...

On September 12, 2025, Acadia Pharmaceuticals announced that the journal Developmental Medicine and Child Neurology published interim results from the LOTUS study, showing caregiver-reported improvements in behavioral symptoms among Rett syndrome patients prescribed DAYBUE under routine clinical care in the U.S. The study provides early real-world evidence of both effectiveness and management of gastrointestinal symptoms for patients receiving DAYBUE, highlighting its impact on various age...

If you’re holding or eyeing SentinelOne (NYSE:S), today’s news may feel like a tipping point. The company just revealed a strategic pairing with Schwarz Digits to roll out an AI-powered cybersecurity solution across Europe, directly targeting data sovereignty, compliance, and the rising need for operational resilience. For investors, this partnership is more than just another logo on a press release. It signals SentinelOne’s readiness to serve heavily regulated industries and governments that...

If you have been watching Vertical Aerospace (NYSE:EVTL), this week’s string of breakthroughs likely has your attention. The company just completed Phase 3 of wingborne flight testing for its VX4 prototype, marking a pivotal step towards commercial electric aircraft certification. Add the appointment of Patrick Ky, the former EASA chief, to Vertical’s board, and suddenly the company’s regulatory pathway looks a lot more concrete, giving investors renewed reason to revisit their stance on the...

When a company like Corebridge Financial (CRBG) announces a change at the very top, investors sit up and take notice. The recent news that Marc Costantini will take over as President and CEO effective December 1, 2025, while outgoing CEO Kevin Hogan steps down but remains through a transition phase, could have big implications. Leadership shake-ups at this level tend to spark questions about the company’s strategy, stability, and future direction, especially when the incoming executive brings...

Uranium Energy (UEC) just made a big announcement that could change how investors view the company. They are launching United States Uranium Refining & Conversion Corp., aiming to build America’s largest and most advanced uranium refining and conversion facility. This move has grabbed attention partly because it aligns closely with recent federal policies that support nuclear energy growth and call for a self-reliant, American-controlled fuel supply chain. For investors, this is more than a...

If you’ve tuned into First Horizon (FHN) lately, you might be wondering what’s driving the buzz around this regional bank. With markets moving in unpredictable ways and no single headline event to point to, investors are eyeing First Horizon’s recent trends for clues about where the story could go next. Sometimes, the absence of a clear trigger can be just as telling, sparking questions about whether there is a deeper value or risk lurking beneath the surface. Looking at the numbers, First...

PACS Group announced that Chief Financial Officer Derick Apt resigned earlier this month after an internal investigation found he violated company policies by accepting high-value items from external parties associated with business partners. The company has appointed Executive Vice Chairman and co-founder Mark Hancock as interim CFO while expanding its finance and accounting team, highlighting a swift leadership response during a time of internal scrutiny. We'll explore how changes in...

NCR Atleos recently reported a strong quarter, surpassing analysts’ EPS and EBITDA estimates, and achieving impressive revenue and profitability metrics. This performance highlights the company’s effective execution and signals robust demand for its financial technology solutions amid sector competition. We’ll explore how NCR Atleos’ significant earnings and profitability gains influence its investment narrative and future outlook. We've found 18 US stocks that are forecast to pay a dividend...

Huntington Bancshares (HBAN) recently declared a quarterly cash dividend on its Series I Non-Cumulative Perpetual Preferred Stock, reinforcing its commitment to shareholder value. Over the last quarter, the company's stock price increased by 15%. This performance aligns with the broader market's gains, impacted by an overall 19% increase over the year. The company also reported strong earnings results in July, with net interest income and net income both rising compared to the previous year...

On September 12, 2025, JinkoSolar Holding announced plans to sell up to 300.2 million A shares of its principal operating subsidiary, Jiangxi Jinko, to qualified institutional investors to raise funds, reducing its stake from 58.59% to about 55.59%. This transaction is intended to improve the company’s cash position and business flexibility, supporting future operations and resilience to market risks. We’ll examine how this share sale, intended to strengthen JinkoSolar’s financial...

CRISPR Therapeutics (CRSP) just delivered another move that has investors paying attention. There is no blockbuster news behind this latest shift, but the uptick in daily and weekly returns could have those watching from the sidelines asking if the market is signaling something beneath the surface. With the biotech sector known for rapid swings in sentiment, any fresh momentum in a stock like CRSP is enough to make both bulls and bears wonder what is coming next. Stepping back, CRISPR...

Zoom Communications (ZM) just landed a spot in the 2025 Gartner Magic Quadrant for Contact Center as a Service, just three years after rolling out its own contact center platform. That is a pretty significant milestone, especially considering how competitive this space has become and how much tech vendors rely on Gartner’s Quadrant for validation. For investors, this recognition is an encouraging signal that Zoom’s AI-driven strategy is gaining traction beyond just video calling. This is...

On September 9, 2025, OptimizeRx and Lamar Advertising Company announced a partnership to integrate OptimizeRx’s patented Micro-Neighborhood Targeting (MNT) data with Lamar’s national out-of-home (OOH) advertising inventory, aiming to support highly targeted, data-driven healthcare campaigns across the United States. This collaboration marks a notable development, bringing advanced clinical audience targeting to traditional OOH networks and offering healthcare marketers new ways to achieve...

At its annual general meeting held in the past week, Interparfums, Inc. expanded its Board of Directors to eleven members with the addition of Patrick Bousquet-Chavanne, an accomplished executive in global luxury and retail, and Hervé Bouillonnec, the company’s Chief Commercial Officer who brings deep expertise in luxury brand management and global fragrance markets. The appointments introduce extensive international retail knowledge and commercial strategy experience to the Board at a time...

On September 2, 2025, Performance Food Group Company announced that Sachem Head LP, an activist investor, submitted a notice nominating four candidates for election to its Board of Directors at the upcoming annual meeting. This development points to potential changes in corporate governance, as activist nominations often signal efforts to influence company strategy and board oversight. We'll explore what Sachem Head LP's board nominations could mean for Performance Food Group's growth...

Navitas Semiconductor recently announced advances in silicon carbide and gallium nitride materials for more power-efficient circuits, targeting sectors like electric vehicles and data centers with an expected transition to 800-volt equipment starting next year. This innovation could open up a US$3 billion annual market by 2030, with industry research forecasting strong annual growth for these advanced semiconductors through 2032. We'll examine how strong demand projections for SiC and GaN...

If you’ve been eyeing Leidos Holdings (LDOS) lately, the unveiling of their Sea Dagger Commando Insertion Craft might be what just tipped your hand. The company’s announcement is not just another product drop; it signals a decisive step into next-gen maritime autonomy, combining Leidos’ signature modular tech, AI, and integrated weapon systems for the Royal Navy. For investors, this could be more than military hardware news. It is a real-world nod to Leidos’ expanding influence in strategic...

RareMed Solutions recently announced an expanded partnership with PTC Therapeutics, launching non-commercial pharmacy dispensing services for Sephience™, following its FDA approval for phenylketonuria (PKU) in adult and pediatric patients. This collaboration aims to provide comprehensive patient support and demonstrates how stakeholder partnerships can enhance access and coordination for innovative rare disease therapies. We'll next explore how Sephience's approval and enhanced patient...

In September 2025, Zymeworks Inc. announced it had voluntarily ended clinical development of ZW171, a T cell engager targeting mesothelin-expressing cancers, after assessing Phase 1 trial results in ovarian and non-small cell lung cancer. This move follows a period of significant regulatory progress for zanidatamab, which recently received accelerated and conditional approvals in the US, Europe, and China for HER2-positive biliary tract cancer, and underscores the company's pivot towards...

PG&E (PCG) recently saw the resignation of Executive Vice President Kaled H. Awada, which could have been a significant company event, but did not deviate its share price from general market trends. Over the last quarter, the company's stock price rose by 13.3%, in line with the broader market's upward trajectory, reflecting similar investor optimism seen in indices like the Nasdaq, which closed at record highs. Despite fluctuations in executive management, PG&E's performance, coupled with...

Earlier this month, Vishay Intertechnology introduced two advanced capacitor series targeting high voltage industrial, medical, and automotive applications, featuring improvements in dissipation factor, reliability, and compactness. These product launches reflect Vishay's focus on addressing growing demand in sectors like electric vehicles, renewable energy, and specialty medical equipment through innovation in electronic components. Next, we'll examine how the introduction of enhanced...